These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 27774177)
1. Incidental findings and future testing methodologies: potential application of the ACMG 2013 recommendations. Richardson A J Law Biosci; 2014 Sep; 1(3):378-387. PubMed ID: 27774177 [TBL] [Abstract][Full Text] [Related]
2. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling. Smith LA; Douglas J; Braxton AA; Kramer K J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901 [TBL] [Abstract][Full Text] [Related]
3. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG; Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249 [TBL] [Abstract][Full Text] [Related]
4. Secondary findings: How did we get here, and where are we going? Ormond KE; O'Daniel JM; Kalia SS J Genet Couns; 2019 Apr; 28(2):326-333. PubMed ID: 30821867 [TBL] [Abstract][Full Text] [Related]
5. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG). ACMG Board of Directors Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278 [No Abstract] [Full Text] [Related]
6. Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing. Bowling KM; Thompson ML; Kelly MA; Scollon S; Slavotinek AM; Powell BC; Kirmse BM; Hendon LG; Brothers KB; Korf BR; Cooper GM; Greally JM; Hurst ACE Genome Med; 2022 Nov; 14(1):131. PubMed ID: 36414972 [TBL] [Abstract][Full Text] [Related]
7. The fiduciary relationship model for managing clinical genomic "incidental" findings. Lázaro-Muñoz G J Law Med Ethics; 2014; 42(4):576-89. PubMed ID: 25565622 [TBL] [Abstract][Full Text] [Related]
8. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. May T J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044 [TBL] [Abstract][Full Text] [Related]
9. WHATIF: An open-source desktop application for extraction and management of the incidental findings from next-generation sequencing variant data. Ye Z; Kadolph C; Strenn R; Wall D; McPherson E; Lin S Comput Biol Med; 2016 Jan; 68():165-9. PubMed ID: 25890833 [TBL] [Abstract][Full Text] [Related]
10. Views of nonmedical, health system professionals regarding the return of whole genome sequencing incidental findings. Strong KA; Zusevics KL; Bick DP; Veith R WMJ; 2014 Oct; 113(5):179-84. PubMed ID: 25739160 [TBL] [Abstract][Full Text] [Related]
11. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN; Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022 [No Abstract] [Full Text] [Related]
12. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG). Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S; Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921 [No Abstract] [Full Text] [Related]
13. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories. Ackerman SL; Koenig BA AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714 [TBL] [Abstract][Full Text] [Related]
14. Incidental Findings in Study Participants: What Is the Researcher's Obligation? Schaare D; Ward LD; Boccuto L Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292587 [TBL] [Abstract][Full Text] [Related]
15. Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines. Anderson JA; Hayeems RZ; Shuman C; Szego MJ; Monfared N; Bowdin S; Zlotnik Shaul R; Meyn MS Clin Genet; 2015 Apr; 87(4):301-10. PubMed ID: 25046648 [TBL] [Abstract][Full Text] [Related]
16. [Ethical issues in genome-era]. Kosugi S Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196 [TBL] [Abstract][Full Text] [Related]
17. Preimplantation genetic testing for more than one genetic condition: clinical and ethical considerations and dilemmas. van der Schoot V; Dondorp W; Dreesen JCFM; Coonen E; Paulussen ADC; de Wert G; de Die-Smulders CEM Hum Reprod; 2019 Jun; 34(6):1146-1154. PubMed ID: 31119284 [TBL] [Abstract][Full Text] [Related]
18. Response to "The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)". Nussbaum RL; Haverfield E; Esplin ED; Aradhya S Genet Med; 2019 Dec; 21(12):2836-2837. PubMed ID: 31239557 [No Abstract] [Full Text] [Related]
19. Prevention for those who can pay: insurance reimbursement of genetic-based preventive interventions in the liminal state between health and disease. Prince AE J Law Biosci; 2015 Jul; 2(2):365-395. PubMed ID: 26339500 [TBL] [Abstract][Full Text] [Related]
20. Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology. Hegde M; Bale S; Bayrak-Toydemir P; Gibson J; Jeng LJ; Joseph L; Laser J; Lubin IM; Miller CE; Ross LF; Rothberg PG; Tanner AK; Vitazka P; Mao R J Mol Diagn; 2015 Mar; 17(2):107-17. PubMed ID: 25684271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]